Crinetics Pharmaceuticals Inc CRNX

Set alert

Price alert · CRNX

All alert types
84.95 USD 0.00 0.00%

At close · Aug 31

37.84 -47.11 -55.46%

After hours · Aug 31, 4:00 PM ET

Bid
36.64 × 10
Ask
36.68 × 3
84.92 Day range 85.01
32.30 52-week range 85.01
YTD
+82.49%
1 year
+183.26%
Open
84.96
Prev close
84.95
Mkt cap
9.01B
Vol
8.18M
Avg vol
4.39M
EPS
-5.05
P/E
0.00
Div yield
0.00%
More statistics
Low
84.92
High
85.01
Forward P/E
-20.63
Beta
0.09
Short ratio
2.26
Inst. own
119.21%
Dividend
0.00
Ex-div date
Earnings
Nov 5, 2026
50-d avg
76.93
200-d avg
50.87
1y target
85.00

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for CRNX has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

39.67 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -9.4×
FY 2016: -57.0×FY 2017: -37.1×FY 2018: -13.4×FY 2019: -12.2×FY 2020: -5.8×FY 2021: -10.1×FY 2022: -5.8×FY 2023: -9.6×FY 2024: -13.9×FY 2025: -9.4×
FY 2016 5y median -9.6× FY 2025
P/S 569×
FY 2016: 578×FY 2017: 166×FY 2018: 150×FY 2019: 508×FY 2020: 6051×FY 2021: 1013×FY 2022: 201×FY 2023: 515×FY 2024: 3975×FY 2025: 569×
FY 2016 5y median 569× FY 2025
P/B 4.4×
FY 2016: -54.8×FY 2017: -22.6×FY 2018: -8.4×FY 2019: 5.2×FY 2020: 2.5×FY 2021: 3.3×FY 2022: 3.0×FY 2023: 3.8×FY 2024: 3.1×FY 2025: 4.4×
FY 2016 5y median 3.3× FY 2025
P/FCF -11.4×
FY 2016: -60.1×FY 2017: -34.8×FY 2018: -17.7×FY 2019: -12.9×FY 2020: -6.9×FY 2021: -12.3×FY 2022: -8.1×FY 2023: -12.1×FY 2024: -18.0×FY 2025: -11.4×
FY 2016 5y median -12.1× FY 2025
EV/EBITDA -9.4×
FY 2016: -55.1×FY 2017: -36.2×FY 2018: -11.3×FY 2019: -10.8×FY 2020: -4.6×FY 2021: -8.4×FY 2022: -5.7×FY 2023: -9.7×FY 2024: -13.3×FY 2025: -9.4×
FY 2016 5y median -9.4× FY 2025
EV/Sales 562×
FY 2016: 557×FY 2017: 159×FY 2018: 131×FY 2019: 479×FY 2020: 4796×FY 2021: 831×FY 2022: 195×FY 2023: 514×FY 2024: 3771×FY 2025: 562×
FY 2016 5y median 562× FY 2025
FCF Yield -8.8%
FY 2016: -1.7%FY 2017: -2.9%FY 2018: -5.6%FY 2019: -7.7%FY 2020: -14.5%FY 2021: -8.2%FY 2022: -12.3%FY 2023: -8.3%FY 2024: -5.6%FY 2025: -8.8%
FY 2016 5y median -8.3% FY 2025

Profitability

Gross Margin 86.0%
FY 2016: -765.9%FY 2017: -351.5%FY 2018: -908.2%FY 2019: 6.7%FY 2020: -80178.9%FY 2021: 100.0%FY 2022: 100.0%FY 2023: 100.0%FY 2024: 100.0%FY 2025: 86.0%
FY 2016 5y median 100.0% FY 2025
Operating Margin -6714.8%
FY 2016: -1026.1%FY 2017: -446.3%FY 2018: -1182.5%FY 2019: -4512.3%FY 2020: -105567.6%FY 2021: -9990.9%FY 2022: -3544.1%FY 2023: -5547.2%FY 2024: -32613.5%FY 2025: -6714.8%
FY 2016 5y median -6714.8% FY 2025
Net Margin -6046.2%
FY 2016: -1021.9%FY 2017: -447.8%FY 2018: -1116.8%FY 2019: -4152.1%FY 2020: -103960.6%FY 2021: -9985.3%FY 2022: -3460.4%FY 2023: -5345.9%FY 2024: -28720.7%FY 2025: -6046.2%
FY 2016 5y median -6046.2% FY 2025
ROE -46.9%
FY 2016: 97.0%FY 2017: 61.0%FY 2018: 62.5%FY 2019: -42.3%FY 2020: -43.7%FY 2021: -32.4%FY 2022: -51.8%FY 2023: -39.8%FY 2024: -22.5%FY 2025: -46.9%
FY 2016 5y median -39.8% FY 2025
ROIC -48.9%
FY 2016: -51.4%FY 2017: -61.8%FY 2018: -17.6%FY 2019: -43.9%FY 2020: -43.3%FY 2021: -32.1%FY 2022: -51.6%FY 2023: -37.4%FY 2024: -24.5%FY 2025: -48.9%
FY 2016 5y median -37.4% FY 2025
ROA -41.0%
FY 2016: -47.8%FY 2017: -58.7%FY 2018: -15.8%FY 2019: -38.0%FY 2020: -40.2%FY 2021: -30.7%FY 2022: -46.5%FY 2023: -33.8%FY 2024: -20.8%FY 2025: -41.0%
FY 2016 5y median -33.8% FY 2025

Growth (YoY)

Revenue 640.7%
FY 2016: 0.0%FY 2017: 247.2%FY 2018: 18.7%FY 2019: -50.9%FY 2020: -94.0%FY 2021: 1418.3%FY 2022: 339.4%FY 2023: -15.3%FY 2024: -74.1%FY 2025: 640.7%
FY 2016 FY 2025
Operating Income -52.5%
FY 2016: 0.0%FY 2017: -51.0%FY 2018: -214.6%FY 2019: -87.5%FY 2020: -39.2%FY 2021: -43.7%FY 2022: -55.9%FY 2023: -32.6%FY 2024: -52.2%FY 2025: -52.5%
FY 2016 FY 2025
EPS (diluted) -34.1%
FY 2016: 0.0%FY 2017: -53.5%FY 2018: -237.9%FY 2019: 8.1%FY 2020: -18.0%FY 2021: -15.7%FY 2022: -12.5%FY 2023: -17.1%FY 2024: 0.0%FY 2025: -34.1%
FY 2016 FY 2025
Free Cash Flow -67.0%
FY 2016: 0.0%FY 2017: -72.9%FY 2018: -109.7%FY 2019: -128.4%FY 2020: -32.7%FY 2021: -43.1%FY 2022: -31.3%FY 2023: -46.3%FY 2024: -34.4%FY 2025: -67.0%
FY 2016 FY 2025

Financial Health

Current Ratio 12.3×
FY 2016: 13.9×FY 2017: 16.9×FY 2018: 21.0×FY 2019: 14.8×FY 2020: 16.9×FY 2021: 21.6×FY 2022: 12.5×FY 2023: 13.1×FY 2024: 23.0×FY 2025: 12.3×
FY 2016 5y median 13.1× FY 2025
Quick Ratio 12.3×
FY 2016: 13.8×FY 2017: 16.7×FY 2018: 21.0×FY 2019: 14.8×FY 2020: 16.9×FY 2021: 21.6×FY 2022: 12.5×FY 2023: 13.1×FY 2024: 23.0×FY 2025: 12.3×
FY 2016 5y median 13.1× FY 2025
Debt / Equity 0.0×
FY 2016: -0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.1×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA 0.1×
FY 2016: 2.0×FY 2017: 1.6×FY 2018: 1.6×FY 2019: 0.7×FY 2020: 1.2×FY 2021: 1.8×FY 2022: 0.2×FY 2023: 0.0×FY 2024: 0.7×FY 2025: 0.1×
FY 2016 5y median 0.2× FY 2025
Interest Coverage 0.0×
FY 2016: -549×FY 2017: -1141×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31